File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Cost-effectiveness study on influenza prevention in Hong Kong

TitleCost-effectiveness study on influenza prevention in Hong Kong
Authors
Issue Date2001
PublisherElsevier Ireland Ltd. The Journal's web site is located at http://www.elsevier.com/locate/healthpol
Citation
Health Policy, 2001, v. 56 n. 3, p. 215-234 How to Cite?
AbstractIntroduction: Recent studies confirm that influenza vaccination confers health benefits and reduces direct and indirect costs associated with the illness. However, these studies did not examine the situation in southern China, a hypothetical influenza epicentre for the emergence of pandemic influenza viruses. Methods: Surveillance data were collected in Hong Kong in 1993/94 and used economic model was used to estimate the medical and social costs associated with influenza-like illness (ILI) and to predict the cost-effectiveness of implementing an influenza prevention programme. Findings: The estimated ILI incidence was 110/1000. It was highest in those between 1 and 25 years of age while the rate of hospitalization was highest in the elderly. Influenza occurred throughout the study period, which was a mild influenza year. The model predicted more than 660 000 ILI cases in a non-epidemic year, in which influenza B virus predominated, with an average ILI-associated cost of HK$283/case (US$36) and vaccination-associated costs of HK$74 (US$9.50) per vaccinated individual. Conclusion: The medical, social and monetary costs of ILI in Hong Kong were not observed to be large when compared with those in more developed countries where there is a clearly defined influenza season and recognized disease burden. From the perspective of a susceptible individual, the vaccine was cost-effective but from the perspective of society it was not, even with the most cost-effective strategy of targeting the elderly. However, if the vaccine were effective in controlling newly emerging and highly virulent strains, targeted vaccination programmes might be highly cost-effective. Copyright © 2001 Elsevier Science Ireland Ltd.
Persistent Identifierhttp://hdl.handle.net/10722/151558
ISSN
2015 Impact Factor: 2.035
2012 SCImago Journal Rankings: 0.733
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorFitzner, KAen_US
dc.contributor.authorShortridge, KFen_US
dc.contributor.authorMcghee, SMen_US
dc.contributor.authorHedley, AJen_US
dc.date.accessioned2012-06-26T06:24:39Z-
dc.date.available2012-06-26T06:24:39Z-
dc.date.issued2001en_US
dc.identifier.citationHealth Policy, 2001, v. 56 n. 3, p. 215-234en_US
dc.identifier.issn0168-8510en_US
dc.identifier.urihttp://hdl.handle.net/10722/151558-
dc.description.abstractIntroduction: Recent studies confirm that influenza vaccination confers health benefits and reduces direct and indirect costs associated with the illness. However, these studies did not examine the situation in southern China, a hypothetical influenza epicentre for the emergence of pandemic influenza viruses. Methods: Surveillance data were collected in Hong Kong in 1993/94 and used economic model was used to estimate the medical and social costs associated with influenza-like illness (ILI) and to predict the cost-effectiveness of implementing an influenza prevention programme. Findings: The estimated ILI incidence was 110/1000. It was highest in those between 1 and 25 years of age while the rate of hospitalization was highest in the elderly. Influenza occurred throughout the study period, which was a mild influenza year. The model predicted more than 660 000 ILI cases in a non-epidemic year, in which influenza B virus predominated, with an average ILI-associated cost of HK$283/case (US$36) and vaccination-associated costs of HK$74 (US$9.50) per vaccinated individual. Conclusion: The medical, social and monetary costs of ILI in Hong Kong were not observed to be large when compared with those in more developed countries where there is a clearly defined influenza season and recognized disease burden. From the perspective of a susceptible individual, the vaccine was cost-effective but from the perspective of society it was not, even with the most cost-effective strategy of targeting the elderly. However, if the vaccine were effective in controlling newly emerging and highly virulent strains, targeted vaccination programmes might be highly cost-effective. Copyright © 2001 Elsevier Science Ireland Ltd.en_US
dc.languageengen_US
dc.publisherElsevier Ireland Ltd. The Journal's web site is located at http://www.elsevier.com/locate/healthpolen_US
dc.relation.ispartofHealth Policyen_US
dc.rightsHealth Policy. Copyright © Elsevier Ireland Ltd.-
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshChilden_US
dc.subject.meshChild, Preschoolen_US
dc.subject.meshCost Of Illnessen_US
dc.subject.meshCost-Benefit Analysisen_US
dc.subject.meshHealth Care Costs - Classification - Statistics & Numerical Dataen_US
dc.subject.meshHealth Services Researchen_US
dc.subject.meshHong Kong - Epidemiologyen_US
dc.subject.meshHumansen_US
dc.subject.meshImmunization Programs - Economicsen_US
dc.subject.meshInfanten_US
dc.subject.meshInfluenza Vaccines - Administration & Dosage - Economicsen_US
dc.subject.meshInfluenza, Human - Economics - Epidemiology - Prevention & Controlen_US
dc.subject.meshPopulation Surveillanceen_US
dc.titleCost-effectiveness study on influenza prevention in Hong Kongen_US
dc.typeArticleen_US
dc.identifier.emailShortridge, KF: microgen@hkucc.hku.hken_US
dc.identifier.emailMcGhee, SM: smmcghee@hkucc.hku.hken_US
dc.identifier.emailHedley, AJ: hrmrajh@hkucc.hku.hk-
dc.identifier.authorityMcGhee, SM=rp00393en_US
dc.identifier.authorityHedley, AJ=rp00357en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1016/S0168-8510(00)00140-8en_US
dc.identifier.pmid11399347-
dc.identifier.scopuseid_2-s2.0-0034987299en_US
dc.identifier.hkuros57896-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0034987299&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume56en_US
dc.identifier.issue3en_US
dc.identifier.spage215en_US
dc.identifier.epage234en_US
dc.identifier.isiWOS:000168372200003-
dc.publisher.placeIrelanden_US
dc.identifier.scopusauthoridFitzner, KA=7006433472en_US
dc.identifier.scopusauthoridShortridge, KF=34573590200en_US
dc.identifier.scopusauthoridMcGhee, SM=7003288588en_US
dc.identifier.scopusauthoridHedley, AJ=7102584095en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats